The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Market Overview

• Strong Growth in Recent Years: The small volume parenteral market has seen significant growth, increasing from $163.34 billion in 2023 to $177.26 billion in 2024, reflecting a CAGR of 8.5%.
• Historic Growth Drivers: Key factors include rising chronic disease prevalence, regulatory approvals, government initiatives, pharmaceutical outsourcing, and globalization.

Future Market Projections

• Continued Expansion: The market is expected to reach $247.53 billion by 2028, with a CAGR of 8.7%.
• Key Growth Factors: Future growth will be driven by the biologics market expansion, healthcare infrastructure development, increased hospitalization rates, regulatory approvals, home healthcare shift, rising healthcare investments, and global health crises.

Trends Shaping the Market

• Biocompatible Formulations: Increasing demand for formulations that are compatible with human tissues.
• Patient-centric approaches: Emphasis on personalized medicine and patient-specific treatments.
• Home Healthcare: Growth in home-based medical care solutions.
• Manufacturing Automation: Advancements in automated production processes.
• Therapeutic Area Expansion: Broadening of applications across various therapeutic areas.
• Smart Pump Technologies: Integration of advanced technologies in drug delivery systems.

Read More On The Small Volume Parenteral Market Report 2024 – https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

Driving Factors

• Rising Surgery Rates: The growing number of surgeries, driven by medical advancements and an aging population, is boosting the demand for small volume parenteral solutions.
  • Use in Surgeries: These solutions are crucial for administering medications, electrolytes, and nutrients directly into the bloodstream.
  • Surgery Statistics: For example, the American Academy of Facial Plastic and Reconstructive Surgery reported 1.4 million surgical and non-surgical plastic surgeries in 2021.

Leading Companies

• Market Leaders: Key players include Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, and more.
  • Innovations: Companies are focusing on innovative production systems like the Pharmatec SVP process systems.
  • Syntegon’s SVP Essential: Launched in March 2021, this system is designed for cost-efficiency and high quality in sterile manufacturing.

Strategic Acquisitions

• Eris Lifesciences’ Acquisition: In February 2024, Eris Lifesciences Ltd. acquired a 51% stake in Swiss Parenteral for $76.52 million, enhancing its presence in the sterile injectables market.

Market Segmentation

• By Type: Ampules, Vials, Prefilled Syringes.
• By Dose Type: Single Dose, Multiple Dose.
• By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorder Or Diarrhea, Diabetes, Other Indications.
• By Application: Local Anesthetics, Vaccines, Other Applications.
• By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users.

Regional Insights

• North America: Largest market region in 2023.
• Asia-Pacific: Expected to be the fastest-growing region in the forecast period.

The small volume parenteral market continues to evolve, driven by technological advancements, strategic acquisitions, and a growing demand for efficient and effective drug delivery solutions.

Request for A Sample Of The Global Small Volume Parenteral Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15925&type=smp